Compounds > 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one
Page last updated: 2024-09-02

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and Substance Withdrawal Syndrome

2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one has been researched along with Substance Withdrawal Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffiths, RR; Lamb, RJ1
Boast, CA; Gerhardt, SC1

Other Studies

2 other study(ies) available for 2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one and Substance Withdrawal Syndrome

ArticleYear
Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.
    Drug and alcohol dependence, 1984, Volume: 14, Issue:1

    Topics: Animals; Benzodiazepinones; Flumazenil; Humans; Lorazepam; Male; Papio; Pyrazoles; Substance Withdrawal Syndrome; Substance-Related Disorders

1984
Lack of tolerance or withdrawal effects in mice after chronic administration of the non-sedating anxiolytic, CGS 9896.
    Pharmacology, biochemistry, and behavior, 1987, Volume: 26, Issue:3

    Topics: Animals; Diazepam; Drug Tolerance; Male; Mice; Mice, Inbred Strains; Motor Activity; Pyrazoles; Reflex; Seizures; Substance Withdrawal Syndrome

1987